國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 911201      線上人數 : 946
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於NHRI管理 到手機版

    子類別

    期刊論文 [100/101]
    會議論文/會議摘要 [19/24]

    社群統計


    近3年內發表的文件:16(12.80%)
    含全文筆數:119(95.20%)

    文件下載次數統計
    下載大於0次:119(100.00%)
    下載大於100次:115(96.64%)
    檔案下載總次數:64420(1.20%)

    最後更新時間: 2024-12-01 03:13

    上傳排行

    資料載入中.....

    下載排行

    資料載入中.....

    RSS Feed RSS Feed
    跳至:
    或輸入年份:
    由新到舊排序 由最舊的開始

    顯示項目51-75 / 125. (共5頁)
    << < 1 2 3 4 5 > >>
    每頁顯示[10|25|50]項目

    日期題名關聯
    2016-12 Glucocorticoids may compromise the effect of gefitinib in non-small cell lung cancer Oncotarget. 2016 Dec;7(52):85917-85928.
    2016-10-01 The prognostic impact of overall treatment time on disease outcomes of uterine cervical cancer patients: A nationwide cohort study of Taiwan International Journal of Radiation Oncology, Biology, Physics. 2016 Oct 1;96(2S, Suppl.):E301.
    2016-10-01 The influence of hospital volume on disease outcomes of advanced uterine cervical cancer patients: A nationwide cohort study of Taiwan International Journal of Radiation Oncology, Biology, Physics. 2016 Oct 1;96(2S, Suppl.):S15-S16.
    2016-10 The role of pre-treatment plasma Epstein-Barr virus (EBV) DNA as a predictive biomarker of induction chemotherapy for stage IVA or IVB nasopharyngeal carcinoma (NPC) patients - A Subgroup Analysis on Taiwan Cooperative Oncology Group (TCOG) 1303 study Annals of Oncology. 2016 Oct;27(Suppl.6 ):Meeting Abstract 973P.
    2016-09 Trend in and correlates of undergoing radiotherapy in Taiwanese cancer patients' last month of life Journal of Pain and Symptom Management. 2016 Sep;52(3):395-403.
    2016-08 Characteristics and correlates of increasing use of surgery in Taiwanese cancer patients' last month of life, 2001-2010 Annals of Surgery. 2016 Aug;264(2):283-290.
    2016-07 Characteristics of young lung cancer: Analysis of Taiwan's nationwide lung cancer registry focusing on epidermal growth factor receptor mutation and smoking status Oncotarget. 2016 Aug;7(29):46628-46635.
    2016-04 Receipt of life-sustaining treatments for Taiwanese pediatric patients who died of cancer in 2001 to 2010: A retrospective cohort study Medicine. 2016 Apr;95(16):Article number e3461.
    2016-01 S-1 with leucovorin for gastric cancer: How far can it go? Lancet Oncology. 2016 Jan;17(1):12-14.
    2016-01 A phase II study of sequential capecitabine plus oxaliplatin followed by docetaxel plus capecitabine in patients with unresectable gastric adenocarcinoma: The TCOG 3211 clinical trial Medicine. 2016 Jan;95(3):Article number e2565.
    2015-12 Breast cancer quality of care in Taiwan in relation to hospital volume: A population-based cohort study Asia-Pacific Journal of Clinical Oncology. 2015 Dec;11(4):308-313.
    2015-12 A decade of changes in preferences for life-sustaining treatments among terminally Ill patients with cancer Journal of the National Comprehensive Cancer Network. 2015 Dec;13(12):1510-1518.
    2015-12 A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma-TCOG 3211 clinical trial Journal of Gastroenterology and Hepatology. 2015 Dec;30(Suppl. S4):99.
    2015-11 Determinants of hospital death for Taiwanese pediatric cancer decedents, 2001–2010 Journal of Pain and Symptom Management. 2015 Nov;50(5):685-692.
    2015-08 Increasing receipt of high-tech/high-cost imaging and its determinants in the last month of Taiwanese patients with metastatic cancer, 2001-2010: A retrospective cohort study Medicine. 2015 Aug;94(32):Article number e1354.
    2015-05 Preferences for aggressive end-of-life care and their determinants among Taiwanese terminally Ill cancer patients Cancer Nursing. 2015 May;38(3):E9-E18.
    2015-05 A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma: The TCOG T3211 trial Journal of Clinical Oncology. 2015 May;33(15, Suppl.):4024.
    2015-04 Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide Hepatology International. 2015 Apr;9(2):258-268.
    2015-04 Long-term outcome of chemotherapy-induced HBV reactivation in lymphoma patients with resolved HBV infection Journal of Hepatology. 2015 Apr;62, Suppl. 2:S563.
    2014-12 Physician-patient end-of-life care discussions: Correlates and associations with end-of-life care preferences of cancer patients-a cross-sectional survey study Palliative Medicine. 2014 Dec;28(10):1222-1230.
    2014-07 Associations between accurate prognostic understanding and end-of-life care preferences and its correlates among Taiwanese terminally ill cancer patients surveyed in 2011–2012 Psycho-Oncology. 2014 Jul;23(7):780-787.
    2014-06 Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study Hepatology. 2014 Jun; 59(6):2092-2100
    2014-05 Celecoxib plus chemoradiotherapy for locally advanced rectal cancer: A phase II TCOG study Journal of Surgical Oncology. 2014 May;109(6):580-585.
    2012-10 Development and validation of an instrument for the measurement of Health-Related Quality of Life Based on View of Traditional Chinese Medicine Perspective Journal of Traditional and Complementary Medicine. 2012 Oct;2(4):295-300.
    2012-04 Use of chemotherapy at the end of life among Taiwanese cancer decedents, 2001-2006 Acta Oncologica. 2012 Apr;51(4):505-511.

    顯示項目51-75 / 125. (共5頁)
    << < 1 2 3 4 5 > >>
    每頁顯示[10|25|50]項目

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋